Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients

Resistance to implementing policy change: the case of Ukraine

(2010) Rifat Atun et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Variability in drug metabolizing enzyme activity in HIV-infected patients

(2010) Amanda E. Jones et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV‐Infected Cohort of Adults with Tuberculosis from Botswana

(2009) Sekai Chideya et al.   CLINICAL INFECTIOUS DISEASES

Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption

(2008) J. J. Wilkins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil

(2008) L. G. Possuelo et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

The early bactericidal activity of anti-tuberculosis drugs: a literature review

(2008) P.R. Donald et al.   TUBERCULOSIS

Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics

(2007) B.J. Anderson et al.   Annual Review of Pharmacology and Toxicology